Search
for
Sort by
Research 331–360 of 1000+
- Recent advances in thiasteroids chemistry
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Association of Insulin Resistance with Hyperandrogenia in Women
- Genetically modified laboratory mice with sebaceous glands abnormalities
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Calcitriol-resistant rickets with alopecia
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Store-operated calcium channels in skin
- α<sub>1</sub>-AR agonist induced piloerection protects against the development of traction alopecia
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Male‐pattern baldness, common latent viruses, and microcompetition
- Anti-Alopecia Activity of Alkaloids Group from Noni Fruit against Dihydrotestosterone-Induced Male Rabbits and Its Molecular Mechanism: In Vivo and In Silico Studies
- Skin Tissue: A Place for SARS-CoV-2 to Multiply and Transmit?
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- Implanon<sup>®</sup> and alopecia
- Topical Melatonin in Androgenetic Alopecia: Mechanisms of Action and Current Clinical Evidence
- АСПЕКТИ ПАТОГЕНЕЗУ ТА ДИФЕРЕНЦІЙОВАНІ ПІДХОДИ ДО ЛІКУВАННЯ ПАТОЛОГІЇ ШКІРИ У ЖІНОК РАННЬОГО РЕПРОДУКТИВНОГО ВІКУ З ПОРУШЕННЯМИ МЕНСТРУАЛЬНОГО ЦИКЛУ
- Molecular Docking Studies and ADME-Tox Prediction of Phytocompounds from Lycopersicon esculentum mill. as a Drug Candidate for Alopecia Treatment
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Polydeoxyribonucleotide in Skincare and Cosmetics: Mechanisms, Therapeutic Applications, and Advancements Beyond Wound Healing and Anti-aging
- Pathogenesis and management of TRPV3-related Olmsted syndrome
- Molecular docking study of phytochemical compounds from Kustakudori ennai as a potential anti-alopecia treatment
- Frontal fibrosing alopecia: Iatrogenic endocrine disruption
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”